Ovarian recovery after stem cell transplantation


Autoria(s): LIU, J.; MALHOTRA, R.; VOLTARELLI, J.; STRACIERI, A. B.; OLIVEIRA, L.; SIMOES, B. P.; BALL, E. D.; CARRIER, E.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2008

Resumo

Autologous or allogeneic SCT with conventional conditioning (chemotherapy with or without irradiation) has emergedas an effective and potentially curative therapy in patients with hematologic malignancies and in other selected solid tumors; however, several patients experience significant early and delayed side effects, including long-term endocrine imbalance and infertility. In spite of several reproductive recovery and pregnancy reports published in the oncology literature, review of medical literature reveals a paucity of comparable information in the SCT field. We report here four cases of ovarian recovery in patients who received hormonal replacement therapy after diagnosis of primary ovarian failure due to high-dose chemotherapy and SCT.

Identificador

BONE MARROW TRANSPLANTATION, v.41, n.3, p.275-278, 2008

0268-3369

http://producao.usp.br/handle/BDPI/24067

10.1038/sj.bmt.1705893

http://dx.doi.org/10.1038/sj.bmt.1705893

Idioma(s)

eng

Publicador

NATURE PUBLISHING GROUP

Relação

Bone Marrow Transplantation

Direitos

restrictedAccess

Copyright NATURE PUBLISHING GROUP

Palavras-Chave #pregnancy #stem cell transplantation #ovarian failure #BONE-MARROW-TRANSPLANTATION #YOUNG-WOMEN #HEMATOLOGICAL MALIGNANCIES #REPLACEMENT THERAPY #HORMONE AGONIST #CHEMOTHERAPY #PREGNANCIES #PROTECTION #LYMPHOMA #CYCLOPHOSPHAMIDE #Biophysics #Oncology #Hematology #Immunology #Transplantation
Tipo

article

original article

publishedVersion